Conduit Pharmaceuticals Inc is a San Diego-based biopharmaceutical company focused on addressing autoimmune diseases and idiopathic male infertility. Founded in 2019, it is pioneering treatments with its leading drugs, AZD1656 and AZD5904, targeting conditions such as hashimoto’s thyroiditis, renal transplant complications, uveitis, preterm labor, and male infertility. As a subsidiary of Corvus Capital Limited, Conduit Pharmaceuticals is at the forefront of developing innovative solutions for critical, unmet medical needs.
Premarket trading is some of my favorite trading to watch. While the market isn’t quite open yet, it’s possible to see some of the biggest moves for the day before the opening…
Joshua Rodriguez 